Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
07/2003
07/17/2003US20030134147 Dendrimers,e.g.,(styryl)n phenyleneamines, allows direct control of the microscopic packing through chemical modification to provide a correlation between molecular structure of the molecules and device semiconductors
07/17/2003US20030133904 Sphingolipids
07/16/2003EP1326824A1 Pharmaceutical compounds
07/10/2003WO2003055599A1 Catalyst supported on carbon having macroporosity for purification of aromatic acids
07/10/2003US20030130509 Process to produce 3-carbon amino alcohol salts
07/10/2003US20030130356 Such as 5,46-dihydroxy-3,8,18,23,28,33,38,43,48-decaazapentacontane decahydrochloride; side effect reduction
07/10/2003US20030130165 Method for treating neurodegenerative disorders
07/09/2003EP1324979A2 Ionic liquids and their use as solvents
07/09/2003EP0901483B1 Benzofurans and benzopyrans as chronobiological agents
07/09/2003CN1429197A Shortened synthesis of 3,3-diarylpropylamine derivatives
07/09/2003CN1113874C Benzocycloalkylazolethione derivatives
07/08/2003US6589295 For use in hair coloring formulations
07/08/2003CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them
07/03/2003WO2003053370A2 Novel developer components
07/03/2003US20030125365 Inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030121110 Novel 1,4-diamino-2-alkenylbenzene derivatives , and dyes containing these compounds
07/02/2003EP1323724A2 Novel ruthenium complexes and process for preparing alcoholic compounds using these
07/02/2003EP1322958A2 Selective binding materials
07/02/2003EP1322593A1 O-substituted 6-methyl-tramadol derivatives
07/02/2003EP1322592A1 Substituted 1-aminobutan-3-ol derivatives
07/02/2003EP1322591A2 Ionic liquids and their use
07/02/2003EP1322590A1 5-amino-1-pentene-3-ol substituted derivatives
07/02/2003EP1322583A1 Method for the isomerisation of allyl alcohols
07/02/2003EP0751952B1 Displacement chromatography of proteins using low molecular weight displacers
07/01/2003US6586633 Antifungal agents
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
06/2003
06/28/2003CA2414265A1 Novel ruthenium complexes and process for preparing alcoholic compounds using these
06/26/2003WO2003051895A1 Processes for preparation of sulphostin and its analogues or intermediates thereof
06/26/2003WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119665 Catalyst for purification of aromatic acids
06/26/2003US20030119031 Fluroescence analysis; controlling transcription factors; bactericides, viricides, anticancer agents, fungicides, antiprotozoa agents
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2469610A1 Method for preparing sulphostin and analogue thereof or preparation intermediate thereof
06/25/2003EP1320534A1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
06/25/2003EP1320522A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/25/2003CN1425656A 1-(alpha-aminobenzyl)-2 naphthol ketal (acetal) compound and its preparation and use
06/25/2003CN1112354C Stereo specific prepn. of chiral 1-aryl-and 1-heteroaryl-2-substituted ethyl-2-amines
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050076A1 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050063A2 PROCESS FOR THE SYNTHESIS OF CHIRALLY PURE β-AMINO-ALCOHOLS
06/19/2003WO2003050062A2 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
06/19/2003US20030114536 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
06/19/2003US20030114528 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030110578 Such as 2-((2-amino-phenylamino)-methyl)-1,4-diaminobenzene; hair dyes
06/19/2003CA2470111A1 Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids
06/19/2003CA2469021A1 Process for the synthesis of chirally pure .beta.-amino-alcohols
06/19/2003CA2468892A1 Vitamin d analogues
06/19/2003CA2467614A1 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
06/18/2003EP1319651A2 2-Aminopropane-1,3-diol compound, pharmaceutical use thereof and synthetic intermediates therefor
06/18/2003EP1142865B1 Novel 1,2-diphenyl-2-propen-1-one derivatives
06/18/2003EP0757677B1 Benzocyclohexylimidazolethione derivatives
06/12/2003WO2003048373A1 Novel substance fki-0550 and process for producing the same
06/12/2003WO2003048105A1 Process and device for producing a colourless triethanolamine
06/12/2003WO2003048104A1 Methods for preparing o-desmethylvenlafaxine
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/11/2003EP1317461A1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories
06/11/2003EP1140789B1 Method for purifying triethanolamine
06/11/2003CN1423630A Quaternary ammonium compounds and their use as anti-tussive agents
06/11/2003CN1422844A Intermediate for preparing substitated biphenyl oxazoline compounds
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003045909A2 Methods and intermediates for the synthesis of azepines
06/05/2003US20030105358 Reacting venlafaxine with high molecular weight alkane or arene thiolate anion in alcohol, ethylene glycol, ethylene glycol ether
06/05/2003US20030105332 Stereoisomers with high affinity for adrenergic receptors
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/04/2003EP1316542A1 3-amino-1-indanole, method of synthesizing the same and method of optical resolution
06/03/2003US6573406 Covering with an alkanolamine-resistant fluoropolymer at least a part of the inner wall of equipment that contacts alkanolamines from the top of the distillation tower to the storage tank in producing high purity alkanolamine from crude
06/03/2003US6573405 Ionic liquids
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
05/2003
05/30/2003WO2003043973A2 Amine phenolic compounds and their use as hardeners and/or accelerators in epoxy coatings
05/29/2003US20030100798 Process for manufacturing triethanolamine and product obtained
05/29/2003US20030100796 Reacting a 3-oxazolidin-5-one derivative with a halomethyl lithium and then treating with an acid
05/29/2003US20030100598 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/28/2003EP1314716A1 Amine phenolic compounds and their use as hardener and/or accelerators in epoxy coatings
05/28/2003EP1313698A2 Process for the preparation of substituted phenylacetonitriles
05/28/2003EP1313694A1 Process for making n-aryl-anthranilic acids and their derivatives
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/27/2003US6570039 Process for producing α-aminoketones
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6569399 Reacting magnesium or reactive magnesium compounds with hydroxy compounds yielding magnesium alkoxides, followed by hydrolysis to form magesium hydroxide or magnesium oxide by calcining of magnesium hydroxide
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042161A1 Venlafaxine hydrochloride polymorphs
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042134A2 Process for the preparation of tertiary amines from primary amines and nitriles
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466442A1 Process for the preparation of tertiary amines from primary amines and nitriles
05/21/2003EP0842658B1 Photostable aqueous solution containing benzyl alcohol derivatives
05/21/2003CN1419573A Mannich bases and further compounds based on alkyldipropylenetriamines as hardeners for epoxy resins
05/20/2003US6566556 From liquid ammonia and an alkylene oxide using a solid catalyst
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 116